4//SEC Filing
Hagan Joseph P 4
Accession 0000950170-25-004274
CIK 0001505512other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 5:00 PM ET
Size
6.8 KB
Accession
0000950170-25-004274
Insider Transaction Report
Form 4
Hagan Joseph P
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-01-09$1.30/sh+62,000$80,600→ 337,862 total - Award
Common Stock
2025-01-09$1.36/sh+218,750$297,500→ 275,862 total
Footnotes (2)
- [F1]On August 10, 2023, the reporting person was granted Restricted Stock Units (RSUs). The RSUs only vest upon achievement of a specified performance-based milestone. The performance criteria were met resulting in immediate vesting of 50% of the shares subject to the grant. The remaining 50% vest on the one year anniversary of the vesting commencement date, subject to the reporting person's Continuous Service to Regulus.
- [F2]On January 12, 2024, the reporting person was granted Restricted Stock Units (RSUs). The RSUs only vest upon achievement of a specified performance-based milestone. The performance criteria were met resulting in immediate vesting of 50% of the shares subject to the grant. The remaining 50% vest on the one year anniversary of the vesting commencement date, subject to the reporting person's Continuous Service to Regulus.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001465278
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 5:00 PM ET
- Size
- 6.8 KB